About Mirador Therapeutics
Mirador Therapeutics is a private company based in San Diego, California, incorporated in 2023 in Delaware. It has reported $412,999,976 raised in two offerings on Form D since April 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2024 | Apr 3, 2024 | $332,999,976fully sold | 31 | $10.7M | EquityRule 506(b) | Form D ↗ |
| Dec 14, 2023 | Apr 3, 2024 | $80,000,000fully sold | 3 | $26.6M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $412,999,976 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mirador Therapeutics's Form D filed Apr 3, 2024.
PB
Paul Berns
Director
TA
Timothy Andrews
Secretary
DD
David Bonita, M.D.
Director
MM
Mark McKenna
Executive officer and director
SG
KB
VB
Vika Brough
Executive officer
JP
Joseph Papa
Director